Q2 2026 Holdings
Filed 2026-08-14 | 12 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $352.6M | 3,705,262 | 23.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $247.3M | 2,537,191 | 16.3% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $226.6M | 8,713,000 | 15.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $213.0M | 5,503,418 | 14.1% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $101.2M | 4,553,494 | 6.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $94.2M | 1,855,644 | 6.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $93.5M | 5,090,928 | 6.2% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $59.9M | 2,359,025 | 4.0% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $49.5M | 2,747,866 | 3.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $39.6M | 298,647 | 2.6% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $18.1M | 722,020 | 1.2% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $17.5M | 8,625,000 | 1.2% |